Characterization of the function and regulation of long noncoding RNA Interferon gamma- anti-sense 1

长链非编码RNA干扰素γ-反义1的功能和调控的表征

基本信息

项目摘要

Project Summary/Abstract The idea that long noncoding RNAs (lncRNA) play an important role in regulating gene expression is a quickly growing concept. The lncRNA IFNG-AS1 is found in a multi-cytokine locus which includes IFNG and IL22. IFNG-AS1 has been shown to play an important role for positively regulating the expression of IFNγ expression in both human and mice. Current research concerning the role for Ifng-as1 suggests its role as a positive regulator of Ifnγ, but preliminary data outlined in this grant shows examples of discordant expression of Ifng-as1 and Ifng. This finding suggests an alternative regulation of this lncRNA. The goal of this proposal is to understand the function and regulation of Ifng-as1 under different cellular settings. In Aim 1 we have proposed to define the relationship between Ifng-as1 and the genome under different cellular settings and different cellular states using HiChIRP (i.e. CD4+ T cells and plasma cells). We will also determine what factors are differentially bound to Ifng-as1 through ATAC-seq and ChIP-seq. We will additionally describe a metabolic role for the regulation of Ifng-as1 in particular glycolysis and glutaminolysis through the use of metabolic inhibitors and nutrient supplementation. In Aim 2 we will define proteins bound to Ifng-as1 through RAP-MS and defined the function of Ifng-as1 by deleting Ifng-as1 and its regulatory elements by using CRISPR/Cas9 technology. Finally, we will seek to determine a role for Ifng-as1 in an in vivo setting for ILC3 differentiation and memory development. The findings from this proposed study will provide novel mechanistic information concerning the regulation of Ifng-as1 and Ifnγ providing novel targets for therapeutic intervention.
项目总结/摘要 长链非编码RNA(lncRNA)在基因调控中起重要作用, 表达是一个快速发展的概念。lncRNA IFNG-AS 1存在于多种细胞因子中, 基因座,包括IFNG和IL 22。IFNG-AS 1已被证明在以下方面发挥重要作用: 在人和小鼠中正调节IFNγ表达。电流 关于Ifng-as 1作用的研究表明,它是Ifnγ的正调节剂,但 本授权中概述的初步数据显示了Ifng-as 1和 Ifng。这一发现表明这种lncRNA的替代调节。这项提案的目的是 了解IFNG-AS 1在不同细胞环境下的功能和调控。目标1 我们已经提出在不同的条件下定义IFNG-AS 1和基因组之间的关系, 使用HiChIRP(即,CD 4 + T细胞和浆细胞)的细胞设置和不同细胞状态。 我们还将确定哪些因子通过ATAC-seq与IFng-as 1差异结合, ChIP-seq.我们还将描述Ifng-as 1调节的代谢作用。 特别是通过使用代谢抑制剂和营养素的糖酵解和氨解 补充。在目标2中,我们将通过RAP-MS定义与IFng-as 1结合的蛋白质, 通过删除Ifng-as 1及其调控元件,定义了Ifng-as 1的功能, CRISPR/Cas9技术。最后,我们将试图确定IFNG-AS 1在体内的作用, ILC 3分化和记忆发育的环境。这项拟议研究的结果 将提供有关Ifng-as 1和Ifnγ调节的新机制信息 为治疗干预提供新的靶点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Danielle Alexandria Chisolm其他文献

Danielle Alexandria Chisolm的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似国自然基金

Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
  • 批准号:
    30801055
  • 批准年份:
    2008
  • 资助金额:
    19.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
  • 批准号:
    BB/Y006224/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
  • 批准号:
    480030
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Operating Grants
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
  • 批准号:
    10083718
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Small Business Research Initiative
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
  • 批准号:
    MR/X009254/1
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
  • 批准号:
    22KJ1758
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
  • 批准号:
    BB/Y000927/1
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
  • 批准号:
    10795212
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
  • 批准号:
    23K18249
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
  • 批准号:
    10735075
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
  • 批准号:
    10645989
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了